Hatch-Waxman Integrity Act of 2018

Fact Sheet API

Bill Number

S 3738

Introduced

Dec 11, 2018

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsor

Cosponsors

Topics

Administrative remedies Drug safety, medical device, and laboratory regulation Fraud offenses and financial crimes Health Intellectual property Licensing and registrations Prescription drugs Securities

Full Text

View Full Bill Text

Votes

Summary

Hatch-Waxman Integrity Act of 2018

This bill amends the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent a generic drug or biosimilar manufacturer from using a specific review process for challenging pharmaceutical drug or biologic patents.

Actions

Dec 11, 2018

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 11, 2018

Introduced in Senate

Amendments

Related Bills